Reply to the Letter to the Editor "Reflections on the statistical methodology in nivolumab and ipilimumab therapy research" by S. Yang.
Saved in:
| Title: | Reply to the Letter to the Editor "Reflections on the statistical methodology in nivolumab and ipilimumab therapy research" by S. Yang. |
|---|---|
| Authors: | Melero I; Department of Immunology, Clinica Universidad de Navarra and CIBERONC, Pamplona, Spain. Electronic address: imelero@unav.es., Soleymani S; Global Biometrics and Data Sciences, Bristol Myers Squibb, Princeton., Tschaika M; Oncology Clinical Development, Bristol Myers Squibb, Princeton., El-Khoueiry AB; USC Norris Comprehensive Cancer Center, Los Angeles, USA. |
| Source: | Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2024 Sep; Vol. 35 (9), pp. 827-828. |
| Publication Type: | Letter |
| Journal Info: | Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 39214632 AccessLevel: 2 PubType: Editorial & Opinion PubTypeId: editorialOpinion PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Reply to the Letter to the Editor "Reflections on the statistical methodology in nivolumab and ipilimumab therapy research" by S. Yang. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Melero+I%22">Melero I</searchLink>; Department of Immunology, Clinica Universidad de Navarra and CIBERONC, Pamplona, Spain. Electronic address: imelero@unav.es.<br /><searchLink fieldCode="AU" term="%22Soleymani+S%22">Soleymani S</searchLink>; Global Biometrics and Data Sciences, Bristol Myers Squibb, Princeton.<br /><searchLink fieldCode="AU" term="%22Tschaika+M%22">Tschaika M</searchLink>; Oncology Clinical Development, Bristol Myers Squibb, Princeton.<br /><searchLink fieldCode="AU" term="%22El-Khoueiry+AB%22">El-Khoueiry AB</searchLink>; USC Norris Comprehensive Cancer Center, Los Angeles, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229007735%22">Annals of oncology : official journal of the European Society for Medical Oncology</searchLink> [Ann Oncol] 2024 Sep; Vol. 35 (9), pp. 827-828. – Name: TypePub Label: Publication Type Group: TypPub Data: Letter – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>9007735 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1569-8041 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2209237534%22">09237534 </searchLink><i>NLM ISO Abbreviation: </i>Ann Oncol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39214632 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.annonc.2024.07.719 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 827 Titles: – TitleFull: Reply to the Letter to the Editor "Reflections on the statistical methodology in nivolumab and ipilimumab therapy research" by S. Yang. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Melero I – PersonEntity: Name: NameFull: Soleymani S – PersonEntity: Name: NameFull: Tschaika M – PersonEntity: Name: NameFull: El-Khoueiry AB IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 09 Text: 2024 Sep Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 1569-8041 Numbering: – Type: volume Value: 35 – Type: issue Value: 9 Titles: – TitleFull: Annals of oncology : official journal of the European Society for Medical Oncology Type: main |
| ResultId | 1 |